September 2023

Home >

Back Issues >

Pharma Manufacturing >

September 2023

September issue of Pharma Manufacturing

September 2023

Digital Edition

Meeting new sustainability targets

Sept. 26, 2023

Sustainability in pharma is complex, but there are opportunities for drugmakers and building developers to meet green goals

Ready for the next revolution?

Sept. 26, 2023

How the industry can build a truly people-centered approach to technology integration

Elevating cold chain logistics

Sept. 26, 2023

How the pandemic spurred a technology evolution for temperature-sensitive products

Shedding stigmas

Sept. 20, 2023

Modern-day medications might finally mean obesity can be viewed as treatable

Modernizing equipment qualification

Sept. 19, 2023

How cutting-edge technologies can streamline and enhance equipment validation processes

More content from September 2023

Pharma's weight loss challenge: Nourishing an obesity market

Sept. 14, 2023

In part 2 of our series on incretin mimetics, we cover the growth of GLP-1 analogues in obesity

Pharma's weight loss challenge: Rewriting the script for obesity care

Sept. 14, 2023

In the third and final part of our series on incretin mimetics, we address pharma’s efforts to overcome supply and pricing issues

Pharma's weight loss challenge: The incretin effect

Sept. 14, 2023

This three-part series will dig into incretin mimetics, their rise to fame in weight management and what it will take for the drug class to truly transform obesity care

Decentralizing pharma data

Sept. 14, 2023

How data mesh can help the pharma industry free data from silos